我的性奴的肉玩具1一17心奴,天堂a免费视频在线观看,久久久久久欧美精品无码,26uuu国产精品色噜噜

產品資料
  首頁 >>> 產品目錄 >>> 細胞生物學 >>> 質粒

pcDNA5/FRT/TO

如果您對該產品感興趣的話,可以
產品名稱: pcDNA5/FRT/TO
產品型號:
產品展商: HZbscience
產品文檔: 無相關文檔

簡單介紹

pcDNA5/FRT/TO的各批次質粒菌株發(fā)貨前均經過嚴格的多重驗證,如存在質量問題,請在收到產品的三個月內通知我司。收到pcDNA5/FRT/TO后請短暫離心,取2μl轉化至對應感受態(tài)中,挑取單克隆重新提取質粒后使用。


pcDNA5/FRT/TO  的詳細介紹

pcDNA5/FRT/TO載體基本信息

載體名稱: pcDNA5/FRT/TO
質粒類型: 哺乳動物細胞表達載體;cDNA表達載體;定向重組載體;四環(huán)素調控載體
高拷貝/低拷貝: 高拷貝
克隆方法: 限制性內切酶,多克隆位點
啟動子: CMVTO(CMV/TetO2)
載體大小: 5137 bp
5' 測序引物及序列: CMV Forward: 5’-CGCAAATGGGCGGTAGGCGTG-3’
3' 測序引物及序列: BGH Reverse: 5’-TAGAAGGCACAGTCGAGG-3’
載體標簽: 無標簽
載體抗性: 氨芐青霉素
篩選標記: 潮霉素(Hygromycin)
克隆菌株: TOP10, DH5α, JM109
宿主細胞(系): Invitrogen公司出品的Flp-In細胞系,293、CV-1、CHO等
備注: pcDNA5/FRT/TO載體是cDNA的表達與克隆載體;
CMVTO啟動子受四環(huán)素調控;
含有FRT位點(重組酶識別位點) ,與pOG44載體共轉染,利用重組酶進行定向重組。
產品目錄號: V6520-20
穩(wěn)定性: 瞬表達 或 穩(wěn)表達
組成型/誘導型: 誘導型
病毒/非病毒: 非病毒

pcDNA5/FRT/TO載體質粒圖譜和多克隆位點信息

pcDNA5-FRT-TO載體圖譜



pcDNA5-FRT-TO特征位點



pcDNA5-FRT-TO 多克隆位點

pcDNA5-FRT-TO 載體特征1
pcDNA5-FRT-TO 載體特征2

pcDNA5/FRT/TO載體簡介

簡介 pcDNAFRTTO vector is a 5.1 kb inducible expression vector designed for use with the Flp-In T-REx System. The control plasmid, pcDNA5FRTTOCAT, is also included for use as a positive control for transfection and expression in your Flp-In T-REx host cell line of choice.

pcDNA5/FRT/TO is a 5.1 kb inducible expression vector designed for use with the Flp-In T-REx System (Cat. no. K6500-01) available from Invitrogen. When cotransfected with the pOG44 Flp recombinase expression plasmid into a Flp-In T-REx mammalian host cell line, the pcDNA5/FRT/TO vector containing the gene of interest is integrated in a Flp recombinase-dependent manner into the genome. Expression of the gene of interest may be induced by the addition of tetracycline to the culture medium. pcDNA5/FRT/TO載體含有以下元件: A hybrid human cytomegalovirus (CMV)/TetO2 promoter for high-level, tetracycline-regulated expression of the gene of interest in a wide range of mammalian cells (Andersson et al., 1989; Boshart et al., 1985; Hillen and Berens, 1994; Hillen et al., 1983; Nelson et al., 1987)
 Multiple cloning site with 10 unique restriction sites to facilitate cloning the gene of interest
 FLP Recombination Target (FRT) site for Flp recombinase-mediated integration of the vector into the Flp-In T-REx host cell line 
 Hygromycin resistance gene for selection of stable cell lines (Gritz and Davies, 1983)
The control plasmid, pcDNA5/FRT/TO/CAT, is included for use as a positive control for transfection and expression in the Flp-In T-REx host cell line of choice.
For more information about the Flp-In T-REx System, the pOG44 plasmid, and generation of the Flp-In T-REx host cell line, refer to the Flp-In T-REx Core Kit manual.

雜交 CMV/TetO2 啟動子 Expression of your gene of interest from pcDNA5/FRT/TO is controlled by the strong CMV immediate early enhancer/promoter (Andersson et al., 1989; Boshart et al., 1985; Nelson et al., 1987) into which 2 copies of the tet operator 2 (TetO2) sequence have been inserted in tandem. Insertion of these TetO2 sequences into the CMV promoter confers regulation by tetracycline to the promoter. The TetO2 sequences consist of 2 copies of the 19 nucleotide sequence, 5′-TCCCTATCAGTGATAGAGA-3′ separated by a 2 base pair spacer (Hillen and Berens, 1994; Hillen et al., 1983). Each 19 nucleotide TetO2 sequence serves as the binding site for 2 molecules of the Tet repressor. For more information about the mechanism of tetracycline regulation in the Flp-In T-REx System, refer to the Flp-In T-REx Core Kit manual. 關于pcDNA5/FRT/TO需要注意的事項 The pcDNA5/FRT/TO vector contains a single FRT site immediately upstream of the hygromycin resistance gene for Flp recombinase-mediated integration and selection of the pcDNA5/FRT/TO plasmid following cotransfection of the vector (with pOG44) into Flp-In T-REx mammalian host cells. The FRT site serves as both the recognition and cleavage site for the Flp recombinase and allows recombination to occur immediately adjacent to the hygromycin resistance gene. The Flp recombinase is expressed from the pOG44 plasmid.

The hygromycin resistance gene in pcDNA5/FRT/TO lacks a promoter and an ATG initiation codon; therefore, transfection of the pcDNA5/FRT/TO plasmid alone into mammalian host cells will not confer hygromycin resistance to the cells. The SV40 promoter and ATG initiation codon required for expression of the hygromycin resistance gene are integrated into the genome (in the Flp-In T-REx host cell line) and are only brought into the correct proximity and frame with the hygromycin resistance gene through Flp recombinase-mediated integration of pcDNA5/FRT/TO at the FRT site. Flp 重組酶介導的DNA重組 In the Flp-In T-REx System, integration of your pcDNA5/FRT/TO inducible expression construct into the genome occurs via Flp recombinase-mediated intermolecular DNA recombination. The hallmarks of Flp-mediated recombination are listed below.
 Recombination occurs between specific FRT sites (see below) on the interacting DNA molecules
 Recombination is conservative and requires no DNA synthesis; the FRT sites are preserved following recombination and there is minimal opportunity for introduction of mutations at the recombination site
 Strand exchange requires only the small 34 bp minimal FRT site FRT 位點 The FRT site, originally isolated from Saccharomyces cerevisiae, serves as a binding site for Flp recombinase and has been well-characterized (Gronostajski and Sadowski, 1985; Jayaram, 1985; Sauer, 1994; Senecoff et al., 1985). The minimal FRT site consists of a 34 bp sequence containing two 13 bp imperfect inverted repeats separated by an 8 bp spacer that includes an Xba I restriction site . An additional 13 bp repeat is found in most FRT sites, but is not required for cleavage (Andrews et al., 1985). While Flp recombinase binds to all three of the 13 bp repeats, strand cleavage actually occurs at the boundaries of the 8 bp spacer region 
FRT 位點



pcDNA5/FRT/TO 載體使用流程如下: 
pcDNA5-FRT-TO 使用流程



pcDNA5/FRT/TO載體序列

hz-8257R TBX1/Brachyury  先心病相關蛋白TBX1抗體
hz-8258R DGCR2  DGCR2蛋白抗體
hz-8259R DHPS  脫氧輔合酶蛋白抗體
hz-8260R DHPS1  短鏈脫氫還原酶1抗體
hz-8261R DHRS13  短鏈脫氫還原酶13抗體
hz-8262R DHRS7  視網膜短鏈脫氫酶/還原酶家族7抗體
hz-8263R DHRSX  短鏈脫氫酶/還原酶家族X抗體
hz-8264R DHRS4  短鏈脫氫酶/還原酶家族4抗體
hz-8265R DHRS7C  短鏈脫氫酶/還原酶家族7C抗體
hz-8266R DHRS4L2  短鏈脫氫酶/還原酶家族4樣2蛋白抗體
hz-8267R GIMAP1  GTP酶IMAP家族成員1抗體
hz-8268R GIMAP2  GTP酶IMAP家族成員2抗體
hz-8269R GIMAP3  GTP酶IMAP家族成員3抗體
hz-8270R GIMAP4  GTP酶IMAP家族成員4抗體
hz-8271R GIMAP5  GTP酶IMAP家族成員5抗體
hz-8272R GIMAP6  GTP酶IMAP家族成員6抗體
hz-8273R GIMAP7  GTP酶IMAP家族成員7抗體
hz-8274R GIMAP8  GTP酶IMAP家族成員8抗體
hz-8275R GPRIN1  G蛋白調節(jié)誘導神經突增生蛋白1抗體
hz-8276R GPRIN2  G蛋白調節(jié)誘導神經突增生蛋白2抗體
hz-8277R GPRIN3  G蛋白調節(jié)誘導神經突增生蛋白3抗體

滬公網安備 31011702004356號

和林格尔县| 遵义县| 大荔县| 漳浦县| 平昌县| 饶阳县| 邮箱| 绥江县| 浦城县| 神池县| 彝良县| 乌鲁木齐市| 防城港市| 邯郸市| 焦作市| 大名县| 绥中县| 慈溪市| 商南县| 泾川县| 乌兰县| 莫力| 山阴县| 三台县| 华容县| 金沙县| 岳普湖县| 河北省| 台东县| 五家渠市| 峨眉山市| 略阳县| 旺苍县| 乌拉特后旗| 博乐市| 太和县| 中西区| 密山市| 平安县| 新田县| 博乐市|